siRNA targeting decoy receptor 3 enhances the sensitivity of gastric carcinoma cells to 5-fluorouracil

In order to investigate the effects of RNA interference of decoy receptor 3 (DcR3) on the sensitivity of gastric cancer cells to 5-fluorouracil (5-FU) and the relevant mechanisms, siRNA against DcR3 was transfected into the gastric cancer cell line AGS. AGS cells were treated with different doses of 5-FU or for different time periods. The sensitivity of AGS cells to 5-FU was determined. The cell survival rate was detected by MTT assay. The apoptotic rate was determined by DAPI staining, and the expression of related proteins were detected by western blot analysis. The results showed that the cell survival rate was significanlty decreased in the knockdown group compared to the control group at different doses of 5-FU (P<0.01). After different time periods of treatment with 5-FU, the cell survival rate in the knockdown group was significantly decreased compared to the control group, respectively (P<0.01). The apoptotic rate of AGS cells in the knockdown group was increased along with the increasing dose of siRNA. The siRNA against DcR3 enhanced the expression of Fas, FasL, caspase-3 and caspase-8. In conclusion, knockdown of DcR3 by RNA interference enhances apoptosis and inhibits the growth of gastric cancer cells. Downregulation of DcR3 enhances the sensitivity of gastric cancer cells to 5-FU and increased the expression of Fas, FasL and caspase-3/8.

• Publication year

  2012

• Venue

  Experimental and Therapeutic Medicine

• Publication date

  2012-06-08

• Fields of study

  Medicine

• Identifiers
  DOI 10.3892/etm.2012.606PMID 23181119PMCID 3503848
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• DcR3-TL1A signalling inhibits cytokine-induced proliferation of rheumatoid synovial fibroblasts.

  2011cited by this paper
• DcR3 induces cell proliferation through MAPK signaling in chondrocytes of osteoarthritis.

  2011cited by this paper
• Dcr3 inhibit p53-dependent apoptosis in γ-irradiated lung cancer cells

  2010cited by this paper
• The role of FasL and Fas in health and disease.

  2009cited by this paper
• Combined treatment with Denbinobin and Fas ligand has a synergistic cytotoxic effect in human pancreatic adenocarcinoma BxPC‐3 cells

  2009cited by this paper
• Effect of malignant phenomenon on humen SW480 colonic cancer cell line by DcR3-RNA interference

  2009cited by this paper
• High DcR3 Expression Predicts Stage pN2-3 in Gastric Cancer

  2008cited by this paper
• Epigenetic control of MHC class II expression in tumor-associated macrophages by decoy receptor 3.

  2008cited by this paper
• Decoy Receptor 3 Expression in AsPC-1 Human Pancreatic Adenocarcinoma Cells via the Phosphatidylinositol 3-Kinase-, Akt-, and NF-κB-Dependent Pathway1

  2008cited by this paper
• Epigenetic control of MHC-II expression in tumor-associated macrophages

  2008cited by this paper
• DCR3 locus is a predictive marker for 5‐fluorouracil‐based adjuvant chemotherapy in colorectal cancer

  2002cited by this paper
• The prognostic significance of overexpression of the decoy receptor for Fas ligand (DcR3) in patients with gastric carcinomas

  2002cited by this paper
• TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator.

  2002cited by this paper
• A Newly Identified Member of Tumor Necrosis Factor Receptor Superfamily (TR6) Suppresses LIGHT-mediated Apoptosis*

  1999cited by this paper
• Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer

  1998cited by this paper

• Advances in RNAi therapies for gastric cancer: Targeting drug resistance and nanoscale delivery.

  2023cites this paper
• The Role of Decoy Receptor DcR3 in Gastrointestinal Malignancy.

  2022cites this paper
• Decoy receptor 3: an endogenous immunomodulator in cancer growth and inflammatory reactions

  2017cites this paper
• DcR3 induces epithelial-mesenchymal transition through activation of the TGF-β3/SMAD signaling pathway in CRC

  2016cites this paper
• Construction , packaging and identification of RNAi lentiviral vectors carrying the decoy receptor 3 gene

  2016cites this paper